Platelet-derived growth factor blockade on cardiac remodeling following infarction

Molecular and Cellular Biochemistry

Volumn 397, Issue 1-2, 2014, Pages 295-304

  Liu, Chang ^b   Zhao, Wenyuan ^a   Meng, Weixin ^b   Zhao, Tieqiang ^a   Chen, Yuanjian ^a   Ahokas, Robert A ^a   Liu, Hongyu ^b   Sun, Yao ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Interstitial fibrosis; Myocardial infarction; PDGF; Ventricular function

Indexed keywords

COLLAGEN TYPE 1; IMATINIB; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; BENZAMIDE DERIVATIVE; LYMPHOKINE; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PLATELET-DERIVED GROWTH FACTOR A; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; SCDGFB PROTEIN, RAT; TGFB1 PROTEIN, RAT; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROGENESIS; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PROTEIN CONTENT; RAT; SCAR FORMATION; ANIMAL; ANTAGONISTS AND INHIBITORS; FIBROSIS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BENZAMIDES; FIBROSIS; LYMPHOKINES; MALE; MYOCARDIAL INFARCTION; PIPERAZINES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84911875520     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2197-x     Document Type: Article

References (35)

1. Yu CM, Tipoe GL, Wing-Hon Lai K, Lau CP (2001) Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol 38:1207–1215
2. Yang F, Yang XP, Liu YH, Xu J, Cingolani O, Rhaleb NE, Carretero OA (2004) Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Hypertension 43:229–236. doi:10.1161/01.HYP.0000107777.91185.89
3. Martinez Rosas M (2006) Cardiac remodeling and inflammation. Arch Cardiol Mex 76(Suppl 4):S58–S66
4. Payne TR, Oshima H, Okada M, Momoi N, Tobita K, Keller BB, Peng H, Huard J (2007) A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 50:1677–1684. doi:10.1016/j.jacc.2007.04.100
5. Dean RG, Balding LC, Candido R, Burns WC, Cao Z, Twigg SM, Burrell LM (2005) Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem 53:1245–1256. doi:10.1369/jhc.4A6560.2005
6. Drobic V, Cunnington RH, Bedosky KM, Raizman JE, Elimban VV, Rattan SG, Dixon IM (2007) Differential and combined effects of cardiotrophin-1 and TGF-beta1 on cardiac myofibroblast proliferation and contraction. Am J Physiol Heart Circ Physiol 293:H1053–H1064. doi:10.1152/ajpheart.00935.2006
7. Ellmers LJ, Scott NJ, Medicherla S, Pilbrow AP, Bridgman PG, Yandle TG, Richards AM, Protter AA, Cameron VA (2008) Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction. Endocrinology 149:5828–5834. doi:10.1210/en.2008-0165
8. Zhao T, Zhao W, Chen Y, Ahokas RA, Sun Y (2011) Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction. Int J Cardiol 152:307–313. doi:10.1016/j.ijcard.2010.07.024
9. Battegay EJ (1995) Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med (Berl) 73:333–346
10. Piazuelo E, Jimenez P, Lanas A, Garcia A, Esteva F, Sainz R (2000) Platelet-derived growth factor and epidermal growth factor play a major role in human colonic fibroblast repair activities. Eur Surg Res 32:191–196. doi:10.1159/000008762
11. Deuel TF, Pierce GF, Yeh HJ, Shawver LK, Milner PG, Kimura A (1987) Platelet-derived growth factor/sis in normal and neoplastic cell growth. J Cell Physiol Suppl Suppl 5:95–99
12. Borkham-Kamphorst E, van Roeyen CR, Ostendorf T, Floege J, Gressner AM, Weiskirchen R (2007) Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol 46:1064–1074. doi:10.1016/j.jhep.2007.01.029
13. Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S (2006) Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol 45:419–428. doi:10.1016/j.jhep.2006.04.010
14. Floege J, Eitner F, Alpers CE (2008) A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 19:12–23. doi:10.1681/ASN.2007050532
15. Zhao W, Zhao T, Huang V, Chen Y, Ahokas RA, Sun Y (2011) Platelet-derived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol 51:830–838. doi:10.1016/j.yjmcc.2011.06.023
16. Zhao T, Zhao W, Chen Y, Li VS, Meng W, Sun Y (2013) Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts. Am J Physiol Heart Circ Physiol 304:H1719–H1726. doi:10.1152/ajpheart.00130.2013
17. Zhao W, Lu L, Chen SS, Sun Y (2004) Temporal and spatial characteristics of apoptosis in the infarcted rat heart. Biochem Biophys Res Commun 325:605–611
18. Jang SW, Ihm SH, Choo EH, Kim OR, Chang K, Park CS, Kim HY, Seung KB (2014) Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension. Hypertension. doi:10.1161/HYPERTENSIONAHA.113.01866
19. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT (2002) Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 161:1773–1781. doi:10.1016/S0002-9440(10)64454-9
20. Garcia RA, Go KV, Villarreal FJ (2007) Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart. Mol Cell Biochem 300:159–169. doi:10.1007/s11010-006-9379-0
21. Zhao W, Zhao T, Chen Y, Sun Y (2013) Angiotensin 1-7 promotes cardiac angiogenesis following infarction. Curr Vasc Pharmacol
22. Distler JH, Jungel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O (2007) Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum 56:311–322. doi:10.1002/art.22314
23. Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, Lee LB, McMahon G, Grone HJ, Lipson KE, Huber PE (2005) Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201:925–935. doi:10.1084/jem.20041393
24. Ma Y, de Castro Bras LE, Toba H, Iyer RP, Hall ME, Winniford MD, Lange RA, Tyagi SC, Lindsey ML (2014) Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch 466:1113–1127. doi:10.1007/s00424-014-1463-9
25. Huang W, Fridman Y, Bonfil RD, Ustach CV, Conley-LaComb MK, Wiesner C, Saliganan A, Cher ML, Kim HR (2012) A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth. Oncogene 31:4527–4535. doi:10.1038/onc.2011.573
26. Kong D, Wang Z, Sarkar SH, Li Y, Banerjee S, Saliganan A, Kim HR, Cher ML, Sarkar FH (2008) Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells 26:1425–1435. doi:10.1634/stemcells.2007-1076
27. Chen YT, Chang FC, Wu CF, Chou YH, Hsu HL, Chiang WC, Shen J, Chen YM, Wu KD, Tsai TJ, Duffield JS, Lin SL (2011) Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 80:1170–1181. doi:10.1038/ki.2011.208
28. Xue Y, Lim S, Yang Y, Wang Z, Jensen LD, Hedlund EM, Andersson P, Sasahara M, Larsson O, Galter D, Cao R, Hosaka K, Cao Y (2012) PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nat Med 18:100–110. doi:10.1038/nm.2575
29. Ogata T, Miyauchi T, Sakai S, Irukayama-Tomobe Y, Goto K, Yamaguchi I (2002) Stimulation of peroxisome-proliferator. Clin Sci (Lond) 103(Suppl 48):284S–288S. doi:10.1042/CS103S284S
30. Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM (1999) Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31:667–678. doi:10.1006/jmcc.1998.0902
31. Hao J, Wang B, Jones SC, Jassal DS, Dixon IM (2000) Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol 279:H3020–H3030
32. Lijnen PJ, Petrov VV, Fagard RH (2000) Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71:418–435. doi:10.1006/mgme.2000.3032
33. Zhao T, Zhao W, Chen Y, Ahokas RA, Sun Y (2010) Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc Res 80:188–194. doi:10.1016/j.mvr.2010.03.014
34. Hao X, Mansson-Broberg A, Gustafsson T, Grinnemo KH, Blomberg P, Siddiqui AJ, Wardell E, Sylven C (2004) Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction. Biochem Biophys Res Commun 315:1058–1063. doi:10.1016/j.bbrc.2004.01.165
35. Chin A, Zheng J, Duignan IJ, Edelberg JM (2006) PDGF-AB-based functional cardioprotection of the aging rat heart. Exp Gerontol 41:63–68. doi:10.1016/j.exger.2005.10.012